Trial NCT04325698

View at ClinicalTrials.gov 
Org. Study IDs: B7391007

Last trial update was posted on 2021-10-04

MeSH Interventions

Bevacizumab Carboplatin Paclitaxel

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

Advanced Non-squamous NSCLC

Stopping Reasons

The study was terminated as part of the decision by Pfizer to halt its biosimilars programs in China.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID